𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer

✍ Scribed by Esteban C. Gabazza; Osamu Taguchi; Tomoya Yamakami; Motoko Machishi; Hidenori Ibata; Kiyoyuki Tsutsui; Shiro Suzuki

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
629 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Activation of coagulation and fibrinolys
Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer
✍ Eija Olsson; Nils Svartling; Sirpa Asko-Seljavaara; Riitta Lassila πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract Cancer patients are subjected to increased systemic risk of thrombotic events and may therefore be at higher risk of even local thrombosis compromising the outcome of reconstructive microsurgery. Coagulation and fibrinolysis activities were studied serially during and after reconstructi

Myofibroblasts and hyalinized collagen a
Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis
✍ Eugene Y. Kissin; Peter A. Merkel; Robert Lafyatis πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 492 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the correlation between the degree of dermal fibrosis and myofibroblast infiltration using clinical assessments of skin thickness and hardness in systemic sclerosis (SSc). ## Methods Eleven patients with diffuse SSc and 10 healthy controls were evaluated u

Detecting lung cancer in plasma with the
Detecting lung cancer in plasma with the use of multiple genetic markers
✍ Francesca Andriani; Davide Conte; Tiziana Mastrangelo; MariaElena Leon; Cathy Ra πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 125 KB

## Abstract Recent studies have demonstrated the possibility to detect genetic changes in plasma DNA of cancer patients. The goal of this study was to validate a panel of molecular markers for lung cancer detection in plasma DNA. Three markers, p53, FHIT and microsatellite alterations at loci on ch